Page last updated: 2024-08-25

7-hydroxystaurosporine and Liver Neoplasms

7-hydroxystaurosporine has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feitelson, MA; Lin, N; Liu, B; Wu, G; Xu, L	1

Other Studies

1 other study(ies) available for 7-hydroxystaurosporine and Liver Neoplasms

Article	Year
UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines. BMC cancer, 2013, Mar-28, Volume: 13 Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; cdc25 Phosphatases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Checkpoint Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Humans; Inhibitory Concentration 50; Liver Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Staurosporine; Tumor Suppressor Protein p53	2013

Article

Year

UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.

BMC cancer, 2013, Mar-28, Volume: 13

Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; cdc25 Phosphatases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Checkpoint Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Humans; Inhibitory Concentration 50; Liver Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Staurosporine; Tumor Suppressor Protein p53

2013